



An Emerging Target for Brain
Stimulation
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Recent meta-analyses of structural and functional neuroimaging studies are
converging on a collective core of brain regions affected across most psychi-
atric disorders, centered on the dorsal anterior cingulate cortex (dACC) and
anterior insula. These nodes correspond well to an anterior cingulo-insular
(aCIN) or ‘salience’ network, and stand at a crossroads within the functional
architecture of the brain, acting as a switch to deploy other major functional
networks according to motivational demands and environmental constraints.
Therefore, disruption of these ‘linchpin’ areas may be disproportionately dis-
abling, even when other networks remain intact. These regions may represent
promising targets for a new generation of anatomically directed brain stimula-
tion treatments. Here, we review the potential of the psychiatric core areas as
targets for therapeutic brain stimulation in psychiatric disease.
Neurology and Psychiatry: An Intuitive Cartesian Divide
While most organs have one dedicated medical specialty, the brain has been divided into two:
neurology and psychiatry. For a variety of historical reasons (see [1] for an interesting review),
these two specialties have diverged over the course of the 20th century, and today view each
other as separate and distinct. Classically, neurology has laid claim to disorders with identiﬁable
‘organic’ lesions in the central nervous system, leaving psychiatry to focus on disorders variously
described as ‘functional’, ‘psychogenic’, or ‘supratentorial’ in origin, which have historically
lacked readily identiﬁable lesions [2].
Yet, the schism cannot be neatly explained simply in terms of the presence or absence of brain
pathology. Many brain disorders with well-established neuropathological abnormalities [e.g.,
bipolar disorder (BP), schizophrenia (SCZ), and obsessive-compulsive disorder (OCD)] are
studied almost exclusively in psychiatric journals. Conversely, other brain disorders with well-
established effects on mood, behavior, and social interaction (e.g., Huntington's disease,
Alzheimer's and Parkinson's dementia, and multiple sclerosis) are overwhelmingly allocated
toward neurological journals (Figure 1).
The polarization of brain medicine into two specialties may in part reﬂect an intuitive Cartesian
dualism in human psychology. Children intuitively accept that certain mental functions, such as
perception, planning, or mental calculation, require the brain; however, other functions, such as
emotion, desire, belief, or pretense, are independent of the physical organ [3]. Related studies
have demonstrated that even adults struggle to acquire scientiﬁc knowledge that clashes with
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the innate intuitions of childhood, and tend to revert to intuition for unfamiliar scenarios [4]. Thus,
one intriguing possibility is that early failures to identify structural lesions for certain brain
disorders, coupled with an innate human reluctance to ascribe certain mental functions to
the organ itself, allowed two separate disciplines of brain medicine to emerge. This resulted in the
current situation: a Cartesian divide between neurology, for disorders of the ‘wires’, and
psychiatry, for disorders of the ‘psyche’.
‘Where is the Lesion?’ in Psychiatry: New Clues from Neuroimaging
Intuitions of dualism aside, it is now clearer than ever that disorders of the ‘psyche’ are also
disorders of the wiring. Since the 1980s, psychiatric neuropathology became amenable to in
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Meningitis 0.988 99.4% 482 3 485
Multiple sclerosis 0.986 99.3% 3752 27 3779
Parkinson 0.985 99.3% 1457 11 1468
Migraine 0.952 97.6% 1060 26 1086
Stroke 0.950 97.5% 3991 103 4094
Huntington 0.931 96.5% 195 7 202
Epilepsy 0.919 96.0% 3276 138 3414
Headache 0.913 95.6% 1093 50 1143
Alzheimer 0.848 92.4% 2003 165 2168
Dementia 0.754 87.7% 3772 530 4302
Pain 0.695 84.8% 1258 226 1484
Traumatic brain injury 0.581 79.1% 204 54 258
Mental retardation 0.575 78.8% 282 76 358
Developmental delay 0.540 77.0% 87 26 113
Tourette 0.126 56.3% 103 80 183
Conversion disorder 0.091 54.5% 12 10 22
Delirium –0.306 34.7% 50 94 144
Autism –0.601 19.9% 131 526 657
Asperger –0.765 11.8% 2 15 17
Attention deficit –0.825 8.8% 72 750 822
Somatoform –0.833 8.3% 3 33 36
Anxiety –0.850 7.5% 208 2568 2776
Obsessive compulsive –0.860 7.0% 56 745 801
Post-traumatic stress –0.891 5.4% 5 87 92
Addiction –0.927 3.6% 26 690 716
Major depression –0.938 3.1% 59 1856 1915
Bipolar –0.948 2.6% 49 1830 1879
Substance dependence –0.961 2.0% 2 100 102
Generalized anxiety –0.961 1.9% 5 253 258
Schizophrenia –0.977 1.1% 67 5768 5835
Panic disorder –0.986 0.7% 5 713 718
Alcohol dependence –0.987 0.7% 2 300 302
(B)
(A)
























Figure 1. Allocations of Citations
among Neurological and Psychiatric
Journals for 32 Prevalent Brain
Disorders. (A) Citation counts were deter-
mined using the PubMed database, over
the period from July 1, 1990 to June 30,
2015, searching for appearances of each
search term in the title or abstract of four
top-cited neurological journals (Lancet:
Neurology, Annals of Neurology, Archives
of Neurology, and Neurology), and four
top-cited psychiatric journals (JAMA Psy-
chiatry/Archives of General Psychiatry,
American Journal of Psychiatry, Biological
Psychiatry, and Neuropsychopharmacol-
ogy). The ‘bias’ score in the ﬁrst data col-
umn is based on the percentage of
citations in neurological versus psychiatric
journals, with +1 indicating all-neurological
citations, –1 indicating all-psychiatric cita-
tions, and 0 indicating an even balance of
neurological and psychiatric citations. (B)
Distribution of publication ratios in neuro-
logical and psychiatric journals, for com-
mon brain disorders. Each data point
along the horizontal axis represents the
relative proportion of publications for one
of the 32 common brain disorders listed in
(A) over the past 25 years, as allocated
between the top four most highly cited
neurological and psychiatric journals. The
plot shows a kernel density estimate of the
distribution of these ratios, and reveals a
sharply bimodal allocation of disorders to
either psychiatric or neurological domains,
with few disorders appearing in a balanced
ratio of study across disciplines.
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vivo study, thanks to non-invasive, high-resolution neuroimaging. The structural neuroimaging
technique of voxel-based morphometry (VBM), developed during the late 1990s [5], has been
particularly productive for localizing psychiatric neuropathology. To date, hundreds of ‘ﬁrst-
wave’ VBM studies have compared gray matter structure in healthy controls versus patients with
psychiatric illnesses.
To sift this wealth of data, researchers have developed quantitative meta-analytic algorithms,
such as activation likelihood estimation (ALE) [6,7], which enable robust statistical inferences
about the spatial consistency of reported abnormalities, across combined samples of hundreds
of patients. Over the past 5 years, nearly 100 ‘second-wave’ VBM meta-analyses have been
reported. Within psychiatry, the ﬁrst reports appeared for SCZ [8,9], followed swiftly by BD
[10,11], OCD [12,13], autism spectrum disorders (ASD) [14,15], major depression (MDD)
[16,17], attention deﬁcit hyperactivity disorder (ADHD) [8,9], post-traumatic stress disorder
(PTSD) [18,19], panic disorder (PD) [18,20], generalized anxiety disorder (GAD) [20], social
anxiety disorder (SAD) [20], substance dependence disorders, including alcohol [21] and
stimulants [22], and eating disorders, such as anorexia nervosa [23]. As of 2015, this literature
now offers a ﬁrst-draft map of consistently observed structural abnormalities for almost every
major psychiatric disorder in the Diagnostic and Statistical Manual.
Recently, the VBM literature has begun a ‘third-wave’ phase of integration, by performing
comparative quantitative meta-analyses not only across studies within a disorder, but also
across disorders themselves [20,24,25]. One recent study applied these methods to address
the distinction between neurological and psychiatric disorders directly [24]. The authors sur-
veyed a range of neurological disorders, including several varieties of movement disorder,
Alzheimer's and frontotemporal dementia, amyotrophic lateral sclerosis, dyslexia, and temporal
lobe epilepsy. Not surprisingly, VBM lesions in neurological disorders extended across diverse
brain regions, including sensorimotor cortex, anterior cingulate and insula, striatum, hippocam-
pus, and thalamus. By contrast, psychiatric disorders (SCZ, BD, OCD, PD, PTSD, ADHD, ASD,
and anorexia) showed a more restricted pattern of VBM changes involving the anterior cingulate,
anterior insula, head of the caudate nucleus, putamen, and anterior hippocampus and amyg-
dala. A direct comparison found more involvement of medial prefrontal cortex, anterior and
posterior cingulate, superior frontal gyrus, and occipital cortex in psychiatric versus neurological
disorders (Figure 2A). Thus, the VBM correlates of psychiatric illness appear to be at least
partially distinct from (and certainly a more restricted set of) the more diverse set of areas seen
across neurological conditions.
Regarding common substrates of psychiatric illnesses, one recent study examined 24 VBM
studies of anxiety disorders, surveying GAD, SAD, PD with and without agoraphobia, and
speciﬁc phobias [20]. Meta-analytic mapping revealed a pattern of overlapping gray matter
reductions in the bilateral pregenual cingulate cortex, right striatum, and right anterior insula, with
similar reductions in the left striatum and anterior insula also appearing in those patients who
were drug naïve (Figure 2B).
Another recent study reported the remarkable ﬁnding of a common neural substrate across
multiple categories of psychiatric illness [25]. Here, the authors used ALE methods to combine
193 studies of mood, anxiety, psychotic, and substance-use disorders in >7000 patients. By
examining different categories of illness separately, the authors identiﬁed both common and
distinctive substrates. For example, psychotic disorders involved a pattern of gray matter loss
extending across medial prefrontal regions, insula, thalamus, and amygdala, as well as gray
matter increases in the left and right striatum. Among nonpsychotic disorders, the ‘internalizing’
disorders of OCD, anxiety disorders, and MDD showed greater gray matter loss in hippocampus
and amygdala that were in contrast to ‘externalizing’ disorders, such as substance abuse.
Trends in Cognitive Sciences, February 2016, Vol. 20, No. 2 109
Yet, there was also a common substrate appearing across every category of disorder: gray
matter volume reductions in the left and right anterior insula, and the dACC (Figure 2C). Although
each illness category also had its own unique neural correlates, these regions appeared
consistently across all psychiatric disorders surveyed. Thus, the emerging picture from structural
neuroimaging is that psychiatric disorders do indeed have ‘organic’ correlates that can be
consistently identiﬁed from sufﬁciently large samples, and that these correlates may be a distinct
subset of regions that are contained within, and do not entirely overlap with, the more diverse set
of areas implicated in neurological illnesses.
A Functional Context for the ‘Common Core’ of Psychiatric Illness
What functions might the psychiatric ‘common core’ regions serve? The functional neuroimag-
ing literature now includes tens of thousands of studies of cognition and behavior in patients and
healthy controls. These studies are catalogued in large databases, amenable to quantitative
meta-analysis techniques similar to those used for structural imaging [26]. Large databases of
resting-state scans in >1000 individuals are also available for interrogation [27,28].
An emerging ﬁnding is that brain regions rarely act in isolation, but rather coordinate their activity
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Figure 2. A Common Core of Regions with Structural Abnormalities in Psychiatric Illness. (A) Brain regions
showing consistent loss of gray matter across a selection of voxel-based morphometry (VBM) studies of diverse psychiatric
illnesses, including schizophrenia (SCZ), bipolar disorder (BD), obsessive-compulsive disorder (OCD), panic disorder (PD),
post-traumatic stress disorder (PTSD), attention deﬁcit hyperactivity disorder (ADHD), autism spectrum disorders, and
anorexia. (B) Brain regions showing consistent loss of gray matter across a variety of anxiety disorders [generalized anxiety
disorder (GAD), social anxiety disorder (SAD), PD with and without agoraphobia, and speciﬁc phobias], shown in blue,
include the right and left insula and associated regions of the striatum, as well as anterior cingulate cortex. (i) Shows changes
in patients with comorbid depression, while (ii) shows patients who are drug naïve. (C) (i) Brain regions showing a loss of gray
matter across multiple categories of psychotic and nonpsychotic psychiatric disorders. Combining both groups, three
nodes emerge: the left and right anterior insula/frontal operculum, and the dorsal anterior cingulate cortex. (ii) These three
nodes belong to a common network of co-activating brain regions seen in meta-analyses of brain activation across multiple
tasks; on resting-state activity, these nodes belong to a larger common network that also includes a circuit of connected
regions in the striatum, thalamus, subthalamic nucleus, and brainstem. Adapted from [24] (A), [20] (B), and [25] (C).
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extracted from ongoing brain activity, using seed-based or data-driven methods, and are
consistent across individuals in the resting state [31]. Remarkably, a similar set of co-activating
networks emerges from meta-analyses of brain activation during task performance [32], sug-
gesting a common functional architecture during either activation or rest. The exact number of
networks is debated; recent studies across a set of 1000 healthy individuals found peaks of
stability for seven- and 17-network parcellations of cortex [33], with corresponding parcellations
in striatum [27] and cerebellum [34] (Figure 3A, Key Figure).
Some of these functional networks are restricted to low-level sensory or motor areas, such as
primary motor cortex, primary visual cortex, or extra-striate cortex (Figure 3B). Others extend
broadly across multimodal regions of the cortex, suggesting a more integrative role. The best
known and most studied is the default-mode network (DMN) [35]. With nodes in the medial
prefrontal cortex, posterior cingulate cortex, precuneus, and lateral parietal cortex, it has
recognized functions for self-referential thinking [36], recollection and prospection [37], and
mind wandering [38]. Although abnormalities in the structure and dynamics of this network
have been described across a variety of neurological psychiatric illnesses [39–43], it is notable
that the ‘core’ regions from VBM meta-analyses of psychiatric illness lie outside the major foci of
the DMN itself.
Another network appears to act in opposition to the introspective functions of the DMN, during
‘extrospective’ activities, such as task performance [44,45]. The so-called ‘task-positive net-
work’ (TPN) includes several subnetworks, such as the central executive network (CEN) [46] or
frontoparietal network (FPN) [47]. The FPN comprises lateral prefrontal and intraparietal areas.
Active during a variety of external-focus cognitive tasks involving working memory or attention,
the FPN may act to control behavior from external cues, on an event-by-event basis [48].
Importantly, while the FPN is consistently active in a variety of ‘general intelligence’-related tasks
involving rule-based behavioral control using external cues [49,50], its nodes have essentially no
overlap with any of the areas seen in VBM meta-analyses of psychiatric illness.
However, another subnetwork appears to be more closely related. This anterior cingulo-insular
network (aCIN) can be reliably separated from the FPN and appears consistently in seven- and
17-network parcellations of functional activity [33] (Figure 3A,B). Often designated as the
‘salience network’ [51] (Figure 3C), its key nodes overlap almost precisely within the areas
identiﬁed as the psychiatric ‘core’: the left and right anterior insula, and the dACC. Its subcortical
components include a larger loop circuit encompassing speciﬁc regions of the striatum, globus
pallidus, subthalamic nucleus, and thalamus, as well as the dopamine-rich substantia nigra and
ventral tegmental area in the brainstem, and speciﬁc regions of the lateral cerebellum
(Figures 2C, 3C). Thus, the psychiatric ‘common core’ maps strikingly well on to a speciﬁc
member of the set of reliably identiﬁable functional networks of the human brain, the aCIN or
‘salience network’. Therefore, it is worth examining the functions of this network in greater detail.
Common Core Functions: Cognitive Control and Response Selection
Meta-analytic tools (e.g., Neurosynth [52]) are now available to mine databases of thousands of
functional imaging studies for brain regions consistently activated for given cognitive function, or
vice versa. Meta-analytic searches using the term ‘salience network’ reveal a set of areas that
map closely on to the aCIN and the psychiatric ‘common core’, as noted above (Figure 3C). Yet,
the aCIN can also be mapped more speciﬁcally on to one of the constructs of the Research
Domain Criteria (RDoC) proposed by the National Institute of Mental Health [53]. The construct of
‘cognitive control’, and speciﬁcally the subconstruct of ‘response selection’, map strikingly well
to the aCIN and common core (Figure 3C), suggesting that deﬁciencies in these functions are a
common element across psychiatric disorders, notwithstanding their differences in other
domains.
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Key Figure
Psychiatric Common Core Regions in the Context of the Functional
Architecture of the Human Brain
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Figure 3. (A) Consistent networks can be identiﬁed within the activity of the resting brain. Seven- and 17-network
parcellations have been reported as being particularly stable across individuals in data sets of 1000 subjects. (B) Replicable
networks include visual, somatomotor, and limbic networks, as well as a default-mode network (DMN) active during rest or
introspection, two to three frontoparietal networks (FPN) active during cognitive tasks or extrospection, and an anterior
cingulo-insular network (aCIN) or salience network (SN), which closely overlaps the common core areas of structural
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Deﬁciencies in self-regulation of emotions, thoughts, and behaviors are indeed a hallmark of
psychiatric illness, and are also consistent with what is known about the functions of the dACC and
anterior insula. The dACC stands midway along a hierarchy of medial prefrontal regions (ranging
from the medial frontopolar cortex anteriorly, to supplementary motor area posteriorly) that guide
goal selection, thought selection, and action selection based on internal drives, as opposed to
external cues [54,55]. The dACC itself contains a posterior region for response selection, a middle
region for decision (action) selection, and an anterior region for strategy selection [56]. Consistent
with this role, the dACC region is active when choosing freely between two different cognitive tasks
[57], and during voluntary, internally cued modulation of emotional states [58].
The insula contains multiple functional subregions, each characterized by different patterns of
functional connectivity to the rest of the brain and different functional roles [59,60]. For example,
posterior insula regions link to low-level somatosensory cortices, and have a proposed lower-
level role in ‘interoception’, or visceral sensory perception [61]; ventral anterior insula regions are
active in chemosensory functions and in mediating disgust [62]. One particular insula subregion,
in dorsal anterior insula, maps well on to the aCIN's anterior insular node, appears in VBM meta-
analyses of psychiatric illness [25], and shows functional connectivity to the other aCIN nodes,
including dACC, frontal opercula, anterior putamen, and mediodorsal thalamus [60]. This
subregion has a role in linking external sensory stimuli to their associated emotional states
[61]. Examples include activation for external stimuli that are salient or behaviorally relevant
[63,64], aversive [65], sad [66], or fearful [58].
The RDoC constructs of internally cued cognitive control and response selection may help unify
the variety of more speciﬁc functions attributed to the dACC and dorsal anterior insula across the
neuroimaging literature. For the dACC, these include conﬂict detection and error detection [67],
impulse regulation [68], suppression of prepotent behavior and cognition [69], the capacity for
counterfactual thought that underlies theory of mind [70], and the modulation of emotional
responses to external stimuli [71]. For the anterior insula, these include activation during errors in
task performance [72], visual observations of another person in pain [73], or visually signaled
rejection during social interaction [74]. In broad terms, the dACC and dorsal anterior insula may
serve two sides of the same function. Where the anterior insula may switch cognition and
emotion states based on external sensory inputs, the dACC may serve a similar function based
on internal states and cues.
This division of labor would be consistent with the broader functional architecture of the
prefrontal cortex, in which a hierarchy of lateral regions guides complex behavior using external
cues, while a corresponding and functionally interconnected hierarchy of medial regions serves
analogous functions based on internal cues [75]. Within this hierarchy, the aCIN nodes would
stand in a crossroads or ‘hub’ position, linking multiple networks mediating cognition and
emotion [76], thus having a prominent role across multiple psychiatric disorders.
abnormality across psychiatric disorders. (C) The common neural substrates across multiple psychiatric illnesses on voxel-
based morphometry (VBM) studies comprise a coherent functional network on resting-state functional connectivity (rsFC)
mapping (i), corresponding closely to the aCIN (ii), which in turn corresponds closely to the set of regions emerging from
Neurosynth meta-analyses of activations in neuroimaging studies of the salience network (iii), and more speciﬁcally of the
Research Domain Criteria construct ‘cognitive control’ (iv) and response inhibition (v). (D) (i) In graph theoretical analyses of
the functional architecture of the brain, the aCIN regions (shown in purple) stand in a ‘crossroads’ position, connecting to
many other subcommunities. By contrast, other communities, such as low-level visual networks (blue), low-level sensor-
imotor networks (cyan), or even the DMN itself (red), are relatively self contained, tightly integrated within themselves but not
widely connected to other communities. (ii) Quantitative measures of network centrality, such as the participation coefﬁcient
(left) and community density (right), are high in the nodes of the aCIN (dorsal anterior cingulate cortex and anterior insula),
supporting the premise that these regions serve as ‘hubs’ or ‘crossroads’ regions within the functional architecture of the
brain as a whole. Adapted from [33] (A) and [76,78] (D).
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A Neural Crossroads for Psychiatric Illness
It is now possible to analyze network architecture in a rigorous, quantitative way using the
mathematical tools of graph theory [77]. Recent studies have applied graph theory to patterns
of resting-state functional connectivity in the human brain, allowing us to both map the larger
functional architecture of the human brain, and situate the major functional networks within this
architecture [78] (Figure 3D). Some networks, such as primary visual or sensorimotor networks, are
tightly integrated but relatively self contained, having less direct interaction with the other networks
of the brain. The DMN, despite its prominent place in brain function, is relatively self contained;
similar to visual cortex, its nodes interact much more with each other than with other networks.
By contrast, the nodes of the aCIN do interact with a variety of other brain networks, and must be
traversed for many trajectories of information ﬂow over the network as a whole. By this criterion,
the aCIN fulﬁlls the deﬁnition of a ‘crossroads’ network [78]. Assessed quantitatively, the aCIN
nodes have a higher participation coefﬁcient and higher community density than the DMN or
other networks, interacting with a broader selection of other brain networks [76] (Figure 3D).
Thus, the aCIN has been proposed to act as a switching system between the FPN and DMN,
activating when brain activity transitions between one and the other [79]. By standing at a
crossroads position between other brain networks, the nodes of the aCIN are better equipped to
integrate the modular functions of the other, more ‘clannish’ networks into a coherent whole.
Functional disruption of the aCIN is apparent in a variety of psychiatric illnesses, including MDD
[80], PTSD [81], and OCD [82]. Conversely, patients with structural lesions of nodes in the aCIN
show impairment across a wider range of neuropsychological functions than do patients with
lesions in the DMN [83]. This observation raises the question of whether treatments that restore
the functioning of the aCIN might have particularly broad-spectrum beneﬁts across psychiatric
disorders, particularly in comorbid cases, by enhancing the general capacity for self-driven
cognitive control and response inhibition.
Targeting the Common Core for Therapeutic Effect
Localizing the neural substrates of psychiatric disease is of limited practical use unless these
substrates can be targeted effectively and selectively; a challenging proposition with medications
or psychotherapy. However, anatomically targeted interventions are now more feasible thanks
to a new, fast-evolving class of treatments: brain stimulation therapies (Box 1). The ‘common
core’ areas in the dACC and anterior insula are notable for being both moderately deep (4–5 cm
from the scalp surface, for both dACC and anterior insula) and moderately focal (2–3 cm in
extent). We consider ﬁrst the evidence that each technique can successfully engage the target
regions, and then the evidence on whether targeting these areas does show therapeutic efﬁcacy
across a broad spectrum of psychiatric disorders, as predicted.
Convulsive Therapies: ECT and MST
In electroconvulsive therapy (ECT), simulations using ﬁnite element modeling (FEM) [84] suggest
that standard bitemporal montages achieve more than adequate penetration of the induced
electrical ﬁeld throughout the cranium. However, focality with ECT is poor and extends well
beyond the common core areas. A bifrontal montage may more selectively target the anterior
insula bilaterally, and a right unilateral montage may have similar effects unilaterally. Newer
proposed montages [85] and ﬁner titration of the current amplitude [86] may achieve still better
focality over the anterior insula, or potentially the dACC. So far, however, no ECT montage or
parameter set has been optimized speciﬁcally to target the cortical components of the ‘core’
brain regions. FEM simulations toward this end may be a fruitful direction for future study.
FEM simulations of magnetic seizure therapy (MST) [84,86] suggest a desirable combination of
moderate depth and moderate focality, in a favorable three-lobed ‘left-centre-right’ spatial
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distribution. In particular, a double-cone inductor placed over the lateral frontal lobes may be well
situated to stimulate the dorsomedial prefrontal region encompassing the dACC. The MST
literature to date is sparse, and the comparative efﬁcacy of different MST montages has not yet
assessed; neither has the full range of potential indications for MST been explored. However, the
good concordance of MST ﬁelds with the ‘common core’ brain regions suggests that MST
should be studied across a wider range of indications than is usual for ECT, such as SCZ. In
general, ECT and MST montages optimized for the aCIN could theoretically prove helpful for
other severe, debilitating psychiatric illnesses that are presently poor indications for convulsive
therapies, such as refractory OCD, PTSD, or anxiety disorders.
Nonconvulsive Therapies: rTMS
Most therapeutic repetitive transcranial magnetic stimulation (rTMS) studies to date, regardless
of indication, have targeted dorsolateral prefrontal cortex (DLPFC) [87]. While DLPFC-rTMS
achieves fair efﬁcacy for MDD [88,89], efﬁcacy in other psychiatric disorders is more modest [90–
93]. DLPFC regions do occur in aCIN/salience network maps (Figure 3), albeit less consistently
than dACC and anterior insula (Figure 3C). Therefore, future rTMS studies might explore whether
targeting these other aCIN nodes might boost remission rates across a wider range of
psychiatric disorders.
The electromagnetic ﬁelds of rTMS are subject to a trade-off between depth and focality [94], so
designing a coil to stimulate the dACC and anterior insula selectively is challenging. However,
FEM simulations suggest that stimulation to the 4–5 cm depth of the dACC and anterior insula is
feasible with commercially available double-cone [95] and helmet-shaped ‘deep TMS’ systems
[96,97], assuming that some stimulation of neighboring regions is acceptable.
Several lines of evidence suggest that stimulation of the dACC is feasible. Double-cone rTMS
can elicit lower limb movements when used to target primary motor cortex for the lower
extremity, 4–5-cm from the scalp surface [98]. Dorsomedial prefrontal rTMS has also been
Box 1. Non-Invasive Brain Stimulation Therapies
Non-invasive brain stimulation techniques for treating psychiatric illness include older approaches, such as electro-
convulsive therapy (ECT), as well as more recently approved methods, such as repetitive transcranial magnetic
stimulation (rTMS), hybrid methods, such as magnetic seizure therapy (MST), and emerging methods, such as
transcranial direct current stimulation (tDCS). Their more invasive counterparts include deep brain stimulation (DBS)
and epidural cortical stimulation (EpCS). All are being used to treat an increasingly wide range of psychiatric illnesses,
from mood and anxiety disorders to substance dependence, psychotic illness, OCD, and eating disorders
ECT applies pulsed electrical currents of approximately 800 mA to the brain to induce a therapeutic generalized tonic-
clonic seizure. The technique is performed under brief general anesthesia, with muscle relaxation to avoid injury from
convulsive movements. Common montages include bilateral stimulation over the temporal poles, right unilateral
stimulation over the right parietal cortex and right temporal pole, or bifrontal stimulation with both electrodes over
the frontal pole. In all cases, stimulation is fairly nonfocal and extends across much of the cerebrum; medial temporal
stimulation is thought to be responsible for the retrograde amnesia that is a common ECT side effect. MST induces the
seizures via a pair of large circular rTMS coils placed over the vertex or the frontal lobes; stimulation is more focal and
penetrates approximately 5 cm from the scalp surface, sparing the medial temporal lobes.
rTMS uses powerful, focused magnetic ﬁeld pulses to induce lasting changes in brain activity. Stimulation coils may have
a circular or ﬁgure of eight shape; ‘deep TMS’ coils use a helmet-shaped array of windings to reach structures >5 cm from
the scalp surface. A typical course involves 20–30 sessions of stimulation. The dorsolateral prefrontal cortex (DLPFC) is
the most common target in the literature to date, with therapeutic effects seen in MDD [88,89]. Other psychiatric
indications under exploration include anxiety disorders, such as PTSD [90], OCD [93], substance dependence [97],
eating disorders [91], and some symptoms of SCZ [122].
tDCS [and its variants, such as transcranial alternating current or random noise stimulation (tACS/tRNS)] use current
amplitudes that are more than 100 times weaker than ECT, and do not produce action potentials. Anodal stimulation is
considered excitatory; cathodal stimulation is considered inhibitory. A limited number of large trials of tDCS suggest some
efﬁcacy in MDD [123,124]; to date, these have exclusively targeted the DLPFC, with left anodal and right cathodal stimulation.
Trends in Cognitive Sciences, February 2016, Vol. 20, No. 2 115
shown directly to activate the dACC on positron emission tomography (PET) [99], to inﬂuence
performance on the Stroop task, which recruits this area [100], and to reduce impulsivity on the
delay-discounting task [101].
Although the most common target for therapeutic rTMS is the DLPFC, a series of recent studies
has begun to demonstrate therapeutic efﬁcacy for dorsomedial rTMS for MDD and BP
[102,103], OCD [104], refractory alcohol dependence [105], ASD [106], binge and purge
behaviors in eating disorders [107], and PTSD [108]. These diverse effects are in keeping with
the involvement of the dACC across multiple categories of psychiatric illness.
Fewer rTMS studies have attempted to target the insula. Double-cone rTMS has been shown to
alter the perception of cold stimuli when applied to the posterior insula [109], suggesting
feasibility. rTMS has also recently been used to target the anterior insular node of the aCIN
speciﬁcally, with changes observed in the resting-state functional connectivity of this network
both within itself and to the FPN [110,111]. Deep TMS of the frontal operculum and anterior
insula, using a helmet-shaped coil, has recently shown efﬁcacy for nicotine dependence, when
applied at high but not low frequency [97] (see Outstanding Questions).
Nonconvulsive Therapies: tDCS
Despite its relatively low ﬁeld strength, there is evidence that transcranial direct current stimula-
tion (tDCS) may be capable of altering the excitability of structures at the depth of the dACC and
anterior insula. For example, anodal tDCS targeting lower limb motor cortex (equivalent to the
depth of dACC) has been shown to potentiate TMS-induced lower limb movements [112].
Anodal tDCS of the dorsomedial prefrontal cortex, neighboring the dACC, has recently been
shown to improve inhibitory control of behavior [113], and to reduce implicit negative bias
towards racial outgroups [114]. Both ﬁndings suggest potential therapeutic utility for enhancing
self regulation of cognition, emotion, and behavior.
Thus far, there is little proof-of-concept evidence available regarding the feasibility of anterior
insular tDCS. FEM simulations support the potential feasibility of stimulating regions of equivalent
or greater depth [115], particularly using the multielectrode montages of high-deﬁnition tDCS
[116]. Therapeutically, few studies of dACC-tDCS or anterior insular tDCS have been reported.
However, tDCS targeting the nearby supplementary motor area has recently been reported to
modulate OCD symptoms, with worsening symptoms after a course of cathodal stimulation and
improvement of symptoms after anodal stimulation [117]. Given the favorable safety and
tolerability proﬁle of tDCS, future studies targeting the dACC and anterior insula in psychiatric
illness should be given high priority.
Neurosurgical Approaches to Brain Stimulation: EpCS and DBS
Epidural cortical stimulation (EpCS) is well suited to targeting the dACC and anterior insula focally
and selectively, since the stimulation contacts can be placed directly upon the cortical surfaces
of these targets. To date, this technique has not been applied to the anterior insula. However,
EpCS has shown therapeutic effect when applied to the medial prefrontal cortex, just anterior to
the dACC, in patients with MDD [118]. However, this study also applied EpCS electrodes to
DLPFC. Since the efﬁcacy of EpCS for refractory MDD has been called into question [119], the
most important implication vis à vis the ‘core’ for this technique might be in encouraging
exploration of evidence-based targets other than the DLPFC, before dismissal of its therapeutic
value in MDD [120].
Deep brain stimulation (DBS) may be better suited to targeting the subcortical components of
the aCIN circuit rather than the dACC and anterior insula directly. As with its approved use in
movement disorders, DBS electrodes targeting the striatum, globus pallidus, or thalamus would
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be expected to modulate the entire cortico-striatal-pallidal-thalamic loop through the target
region, to therapeutic effect [121]. With accurate implantation, one would hypothesize broad-
spectrum effects across a variety of psychiatric symptom categories. Maps of resting and task-
based functional connectivity through the aCIN may offer suggestions for novel DBS implanta-
tion targets in severe psychiatric disease.
Concluding Remarks
The Cartesian divide between the ‘functional’ disorders of psychiatry and the ‘organic’ disorders
of neurology may soon be ending. Quantitative meta-analyses, applied to growing repositories
of neuroimaging data, are helping to localize the neuroanatomical substrates of psychiatric
illness. Strikingly, a common circuit seems to unify most psychiatric disorders, and this circuit
maps fairly neatly on to a speciﬁc network of brain regions: the aCIN. This network occupies a
critical ‘hub’ position within the functional architecture of the brain, which may account for its
prominence in complex functions involving cognition, emotion, behavioral regulation, social
behavior, and theory of mind. When this hub network fails, the corollary could be severely
disabling illness, even if the basic component functions of sensory perception and motor control
remain intact.
The notion of psychiatric dysfunction as an organic ‘illness’ may challenge our intuitions.
However, it need not challenge our progress in developing new treatments. The identiﬁcation
of a discrete set of neural substrates for psychiatric illness arrives at a fortuitous time, just as
anatomically targeted brain stimulation therapies are making the leap from the lab to the clinic.
Optimizing the efﬁcacy of brain stimulation therapies requires that we engage the correct targets.
As a result of a conﬂuence of progress in neuroimaging and brain stimulation, we may soon be
on the cusp of a new generation of more effective therapies in one of the most challenging, yet
most exciting ﬁelds of modern medicine.
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